Search contract descriptions, companies and agencies.
IDT BIOLOGIKA BASE FY20 PROCESS DEVELOPMENT FOR VACCINE CANDIDATES INCLUDING SARS COV 2 CAN 8044363 TOTAL $20,462.00
Total Committed
$583K
Product or Service Description
Biomedical Applied Research/Exploratory Development R&D
Contracting Agency
Effective Date
May 8, 2020
Funding Department
NATIONAL INSTITUTES OF HEALTH NIAID
Type
Fixed price level of effort
Solicitation Procedure
Subject to multiple award fair opportunity
Extent Competed
Full and open competition
Recent Contract Actions 
Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.
| Vendor | Description | Signed | Reason for Change | Amount Committed |
|---|---|---|---|---|
| IDT BIOLOGIKA GMBH | IDT BIOLOGIKA FY20 MASTER CELL BANKS MANUFACTURING FOR PANDEMIC PREPAREDNESS COVID 19 | Sept. 15, 2020 | Funding Only Action | $541,627 |
| IDT BIOLOGIKA GMBH | IDT BIOLOGIKA BASE AWARD FY20 MASTER CELL BANKS MANUFACTURING FOR PANDEMIC PREPAREDNESS COVID 19 CAN 844363 $20,462.00 | May 11, 2020 | $20,462 | |
| IDT BIOLOGIKA GMBH | IDT BIOLOGIKA BASE FY20 PROCESS DEVELOPMENT FOR VACCINE CANDIDATES INCLUDING SARS COV 2 CAN 8044363 TOTAL $20,462.00 | May 8, 2020 | $20,462 |
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.